SAIC 10-K Annual Report Jan. 28, 2022 | Alphaminr
Science Applications International Corp

SAIC 10-K Fiscal year ended Jan. 28, 2022

SCIENCE APPLICATIONS INTERNATIONAL CORP
10-Ks and 10-Qs
10-Q
Quarter ended May 3, 2024
10-K
Fiscal year ended Feb. 2, 2024
10-Q
Quarter ended Nov. 3, 2023
10-Q
Quarter ended Aug. 4, 2023
10-Q
Quarter ended May 5, 2023
10-K
Fiscal year ended Feb. 3, 2023
10-Q
Quarter ended Oct. 28, 2022
10-Q
Quarter ended July 29, 2022
10-Q
Quarter ended April 29, 2022
10-K
Fiscal year ended Jan. 28, 2022
10-Q
Quarter ended Oct. 29, 2021
10-Q
Quarter ended July 30, 2021
10-Q
Quarter ended April 30, 2021
10-K
Fiscal year ended Jan. 29, 2021
10-Q
Quarter ended Oct. 30, 2020
10-Q
Quarter ended July 31, 2020
10-Q
Quarter ended May 1, 2020
10-K
Fiscal year ended Jan. 31, 2020
10-Q
Quarter ended Nov. 1, 2019
10-Q
Quarter ended Aug. 2, 2019
10-Q
Quarter ended May 3, 2019
10-K
Fiscal year ended Feb. 1, 2019
10-Q
Quarter ended Nov. 2, 2018
10-Q
Quarter ended Aug. 3, 2018
10-Q
Quarter ended May 4, 2018
10-K
Fiscal year ended Feb. 2, 2018
10-Q
Quarter ended Nov. 3, 2017
10-Q
Quarter ended Aug. 4, 2017
10-Q
Quarter ended May 5, 2017
10-K
Fiscal year ended Feb. 3, 2017
10-Q
Quarter ended Nov. 4, 2016
10-Q
Quarter ended Aug. 5, 2016
10-Q
Quarter ended May 6, 2016
10-K
Fiscal year ended Jan. 29, 2016
10-Q
Quarter ended Oct. 30, 2015
10-Q
Quarter ended July 31, 2015
10-Q
Quarter ended May 1, 2015
10-K
Fiscal year ended Jan. 30, 2015
10-Q
Quarter ended Oct. 31, 2014
10-Q
Quarter ended Aug. 1, 2014
10-Q
Quarter ended May 2, 2014
10-K
Fiscal year ended Jan. 31, 2014
10-Q
Quarter ended Nov. 1, 2013
10-Q
Quarter ended Aug. 2, 2013
PROXIES
DEF 14A
Filed on April 24, 2024
DEF 14A
Filed on April 26, 2023
DEF 14A
Filed on April 27, 2022
DEF 14A
Filed on April 21, 2021
DEF 14A
Filed on April 22, 2020
DEF 14A
Filed on April 24, 2019
DEF 14A
Filed on April 25, 2018
DEF 14A
Filed on April 26, 2017
DEF 14A
Filed on April 27, 2016
DEF 14A
Filed on April 24, 2015
DEF 14A
Filed on April 24, 2014
TABLE OF CONTENTS
Part IItem 1. BusinessItem 1A. Risk FactorsItem 1B. Unresolved Staff CommentsItem 2. PropertiesItem 3. Legal ProceedingsItem 4. Mine Safety DisclosuresPart IIItem 5. Market For Registrant S Common Equity, Related Stockholder Matters and Issuer Purchase Of Equity SecuritiesItem 6. [reserved]Item 7. Management S Discussion and Analysis Of Financial Condition and Results Of OperationsItem 7A. Quantitative and Qualitative Disclosures About Market RiskItem 8. Financial Statements and Supplementary DataItem 9. Changes in and Disagreements with Accountants on Accounting and Financial DisclosureItem 9A. Controls and ProceduresItem 9B. Other InformationItem 9C. Disclosure Regarding Foreign Jurisdictions That Prevent InspectionsPart IIIItem 10. Directors, Executive Officers, and Corporate GovernanceItem 11. Executive CompensationItem 12. Security Ownership Of Certain Beneficial Owners and Management and Related Stockholder MattersItem 13. Certain Relationships and Related Transactions, and Director IndependenceItem 14. Principal Accounting Fees and ServicesPart IVItem 15. Exhibits, Financial Statement SchedulesItem 16. Form 10-k SummaryNote 1 Business Overview and Summary Of Significant Accounting Policies:Note 2 Earnings Per Share, Share Repurchases and Dividends:Note 3 Revenues:Note 4 Acquisitions:Note 5 Restructuring and Impairment:Note 6 Goodwill and Intangible Assets:Note 7 Property, Plant, and Equipment:Note 8 Stock-based Compensation:Note 9 Retirement Plans:Note 10 Income Taxes:Note 11 Debt Obligations:Note 12 Derivative Instruments Designated As Cash Flow Hedges:Note 13 Changes in Accumulated Other Comprehensive Loss By Component:Note 14 Sale Of Receivables:Note 15 Leases:Note 16 Business Segment Information:Note 17 Legal Proceedings and Commitments and Contingencies:

Exhibits

10.21* Form of Restricted Stock Unit Award Agreement of the Science Applications International Corporation 2013 Amended and Restated Equity Incentive Plan. 10.22* Form of Performance Share Award Agreement of the Science Applications International Corporation 2013 Amended and Restated Equity Incentive Plan. 10.23* Deferred Compensation Plan, effective January 1, 2015. Incorporated by reference to Exhibit 10.17 of the Companys Annual Report on Form 10-K as filed with the SEC on March 31, 2015. 10.24* SAIC Executive Severance, Change in Control and Retirement Policy, effective July 1, 2020. Incorporated by reference to Exhibit 10.1 to the Companys Current Report on Form 8-K as filed with the SEC on July 2, 2020. 10.25 Master Transition Services Agreement dated September 25, 2013, between the Company (formerly SAIC Gemini, Inc.) and Leidos Holdings, Inc. (formerly SAIC, Inc.). Incorporated by reference to Exhibit 10.3 to the Companys Current Report on Form 8-K as filed with the SEC on October 1, 2013. 10.26* Science Applications International Corporation Third Amended and Restated 2012 Long Term Performance Plan. Incorporated by reference to Exhibit 10.19 to the Company's Annual Report on Form 10-K as filed with the SEC on March 29, 2019. 10.27 Master Transitional Contracting Agreement between the Company (formerly SAIC Gemini, Inc.) and Leidos Holdings, Inc. (formerly SAIC, Inc.) dated September 25, 2013. Incorporated by reference to Exhibit 10.1 to the Companys Quarterly Report on Form 10-Q as filed with the SEC on December 13, 2013. 10.28* Form of Performance Unit Award Agreement of the Science Applications International Corporation 2012 Long Term Performance Plan. Incorporated by reference to Exhibit 10.21 to the Company's Annual Report on Form 10-K as filed with the SEC on March 29, 2019. 10.29* Form of Restricted Stock Unit Agreement of the Science Applications International Corporation 2012 Long Term Performance Plan. Incorporated by reference to Exhibit 10.22 to the Company's Annual Report on Form 10-K as filed with the SEC on March 29, 2019. 21 Subsidiaries of Registrant. 23.1 Consent of Ernst & Young LLP, Independent Registered Public Accounting Firm. 31.1 Certification of Chief Executive Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002. 31.2 Certification of Chief Financial Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002. 32.1 Certification of Chief Executive Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002. 32.2 Certification of Chief Financial Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.